Search Results - (Author, Cooperation:E. M. Brown)
-
1B. A. Golomb ; S. Brenner ; M. Chalfie ; S. L. Glashow ; R. J. Glauber ; D. H. Hubel ; E. S. Maskin ; P. Greengard ; D. J. Gross ; R. Roberts ; S. Tonegawa ; F. A. Wilczek ; E. M. Brown ; T. J. Sejnowski
Nature Publishing Group (NPG)
Published 2013Staff ViewPublication Date: 2013-07-28Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: *Cacao ; Diet/*statistics & numerical data ; Humans ; Male ; *Nobel PrizePublished by: -
2Panch, S. R., Bozik, M. E., Brown, T., Makiya, M., Prussin, C., Archibald, D. G., Hebrank, G. T., Sullivan, M., Sun, X., Wetzler, L., Ware, J., Fay, M. P., Dunbar, C. E., Dworetzky, S. I., Khoury, P., Maric, I., Klion, A. D.
American Society of Hematology (ASH)
Published 2018Staff ViewPublication Date: 2018-08-03Publisher: American Society of Hematology (ASH)Print ISSN: 0006-4971Electronic ISSN: 1528-0020Topics: BiologyMedicineKeywords: Phagocytes, Granulocytes, and Myelopoiesis, Clinical Trials and ObservationsPublished by: -
3Habibullah, M., Porter, J. A., Kluger, N., Ranki, A., Krohn, K. J. E., Brandi, M. L., Brown, E. M., Weetman, A. P., Kemp, E. H.
The American Association of Immunologists (AAI)
Published 2018Staff ViewPublication Date: 2018-11-20Publisher: The American Association of Immunologists (AAI)Print ISSN: 0022-1767Electronic ISSN: 1550-6606Topics: MedicinePublished by: -
4T. Schneider ; S. D. Graves ; E. L. Schaller ; M. E. Brown
Nature Publishing Group (NPG)
Published 2012Staff ViewPublication Date: 2012-01-10Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsPublished by: -
5BROWN, E. M. ; DEPARES, J. ; ROBERTSON, A. A. ; JONES, S. ; HUGHES, A. B. ; COLES, E. C. ; MORGAN, J. R.
Oxford, UK : Blackwell Publishing Ltd
Published 1988Staff ViewISSN: 1471-0528Source: Blackwell Publishing Journal Backfiles 1879-2005Topics: MedicineNotes: Summary. In order to determine the most effective regimen for the prevention of infection after elective hysterectomy, 300 patients were randomly assigned to receive three perioperativc doses of either amoxycillin-clavulanic acid (1.2 g intravenous) or metronidazole (1 g suppository). Of the 280 patients who were assessable 138 were given amoxycillin-clavulanic acid and 142 received metronidazole; 268 underwent abdominal hysterectomy and 12 had vaginal hysterectomy. Patients in the amoxycillin-clavulanic acid group had significantly less infectious morbidity (13.8%) than those in the metronidazole group (33.1%). There were also statistically significant differences in favour of amoxycillin-clavulanic acid with respect to operative site infection, duration of hospital stay, need for postoperative antimicrobials, and surgery for operative site infection. But for one isolate of Bacteroides fragilis, all pathogens isolated from wound infections in the metronidazole group were aerobes. No anaerobes were isolated from patients in the amoxycillin-clavulanic acid group. The results suggest that prophylaxis for hysterectomy should consist of an agent, or combination of agents, with activity against both aerobic and anaerobic bacteria. Amoxycillin-clavulanic acid fulfils this criterion and appears to be effective and safe.Type of Medium: Electronic ResourceURL: -
6Staff View
ISSN: 1420-9071Source: Springer Online Journal Archives 1860-2000Topics: BiologyMedicineNotes: Summary Bovine parathyroid glands contain large amounts of dopamine (3.4–13.9 pg/μg), but very little norepinephrine. Fluorescent histochemistry demonstrates only rare adrenergic nerve terminals on vasculature. Single dopamine-containing cells, most likely mast cells, are scattered in large numbers throughout the connective tissue stroma.Type of Medium: Electronic ResourceURL: -
7Reddy, C. S. ; Mohammad, F. K. ; Ganjam, V. K. ; Martino, M. A. ; Brown, E. M.
Springer
Published 1987Staff ViewISSN: 1432-0800Source: Springer Online Journal Archives 1860-2000Topics: Energy, Environment Protection, Nuclear Power EngineeringMedicineType of Medium: Electronic ResourceURL: -
8Yamaguchi, T. ; Ye, C.-P. ; Chattopadhyay, N. ; Sanders, J. L. ; Vassilev, P. M. ; Brown, E. M.
Springer
Published 2000Staff ViewISSN: 1432-0827Keywords: Key words: Calcium-sensing receptor — Promyelocytic leukemia — Monocyte — Macrophage — HL-60 cell.Source: Springer Online Journal Archives 1860-2000Topics: BiologyMedicinePhysicsNotes: Abstract. Human promyelocytic leukemia cells (HL-60) have been used widely as a model for studying the differentiation of hematopoietic progenitor cells in vitro. After treatment with phorbol-12-myristate-13-acetate (PMA) or 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], HL-60 cells differentiate into cells with the phenotype of monocytes/macrophages. We previously showed that peripheral blood monocytes and the murine J774 monocytic cell line express the CaR, and myeloid progenitors in the bone marrow and myeloid cells in peripheral blood other than monocytes express lower levels of the CaR. Therefore, we investigated whether undifferentiated HL-60 cells express a functional G protein-coupled, extracellular calcium (Ca2+ o)-sensing receptor (CaR) and if the expression of the CaR increases as these cells differentiate along the monocytic lineage. The use of reverse transcription-polymerase chain reaction (RT-PCR) with CaR-specific primers, followed by sequencing of the amplified products, identified an authentic CaR transcript in undifferentiated HL-60 cells. Both immunocytochemistry and Western blot analysis using a CaR-specific antiserum detected low levels of CaR protein expression in undifferentiated HL-60 cells. The levels of CaR protein increased considerably following treatment of the cells with PMA (50 nM) or 1,25(OH)2D3 (100 nM) for 5 days. Northern analysis using a CaR-specific riboprobe identified CaR transcripts in undifferentiated HL-60 cells, but CaR mRNA levels did not change appreciably after treatment with either agent, suggesting that upregulation of CaR protein occurs at a translational level. PMA-treated HL-60 cells expressed a nonselective cation channel (NCC), and the calcimimetic CaR activator, NPS R-467, but not its less active stereoisomer, NPS S-467, as well as the polycationic CaR agonist, neomycin, activated this NCC, demonstrating that the CaR expressed in these cells is functionally active. Therefore, HL-60 cells exhibit an increase in CaR protein expression, occurring at a translational level during their differentiation into cells with a monocyte/macrophage phenotype in response to treatment with PMA or 1,25(OH)2D3, which is functionally linked to activation of a nonselective cation channel.Type of Medium: Electronic ResourceURL: -
9Staff View
ISSN: 1432-0827Source: Springer Online Journal Archives 1860-2000Topics: BiologyMedicinePhysicsType of Medium: Electronic ResourceURL: -
10Staff View
ISSN: 1439-0973Source: Springer Online Journal Archives 1860-2000Topics: MedicineType of Medium: Electronic ResourceURL: